271 related articles for article (PubMed ID: 26244718)
1. Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
Boga S; Alkim H; Koksal AR; Bayram M; Ozguven MB; Ergun M; Neijmann ST; Ozgon G; Alkim C
J Investig Med; 2015 Oct; 63(7):871-7. PubMed ID: 26244718
[TBL] [Abstract][Full Text] [Related]
2. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
[TBL] [Abstract][Full Text] [Related]
3. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
[TBL] [Abstract][Full Text] [Related]
4. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
[TBL] [Abstract][Full Text] [Related]
5. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
Dogru T; Genc H; Tapan S; Ercin CN; Ors F; Aslan F; Kara M; Sertoglu E; Bagci S; Kurt I; Sonmez A
Diabetes Res Clin Pract; 2012 Apr; 96(1):47-52. PubMed ID: 22189171
[TBL] [Abstract][Full Text] [Related]
6. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
Hossain IA; Rahman Shah MM; Rahman MK; Ali L
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.
Kasumov T; Edmison JM; Dasarathy S; Bennett C; Lopez R; Kalhan SC
Metabolism; 2011 Jun; 60(6):776-81. PubMed ID: 20869086
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
[TBL] [Abstract][Full Text] [Related]
9. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
10. [Relationship of non-alcoholic steatohepatitis with arterial endothelial function and atherosclerosis].
Cao Y; Li L
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):205-8. PubMed ID: 24824123
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
Chang EJ; Yi DY; Yang HR
J Korean Med Sci; 2015 Dec; 30(12):1821-7. PubMed ID: 26713058
[TBL] [Abstract][Full Text] [Related]
12. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.
Siddiqui MS; Cheang KL; Luketic VA; Boyett S; Idowu MO; Patidar K; Puri P; Matherly S; Stravitz RT; Sterling RK; Sanyal AJ
Dig Dis Sci; 2015 Aug; 60(8):2529-37. PubMed ID: 25784075
[TBL] [Abstract][Full Text] [Related]
14. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.
Xu Q; Li Y; Shang YF; Wang HL; Yao MX
World J Gastroenterol; 2015 Jan; 21(2):511-6. PubMed ID: 25593466
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.
Perticone F; Sciacqua A; Maio R; Perticone M; Galiano Leone G; Bruni R; Di Cello S; Pascale A; Talarico G; Greco L; Andreozzi F; Sesti G
Int J Cardiol; 2010 Jul; 142(3):236-41. PubMed ID: 19168237
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease.
Yeniova AO; Küçükazman M; Ata N; Dal K; Kefeli A; Başyiğit S; Aktaş B; Ağladioğlu K; Akin KO; Ertugrul DT; Nazligül Y; Beyan E
Hepatogastroenterology; 2014; 61(130):422-5. PubMed ID: 24901154
[TBL] [Abstract][Full Text] [Related]
17. Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease.
Hossain IA; Akter S; Bhuiyan FR; Shah MR; Rahman MK; Ali L
BMC Res Notes; 2016 May; 9():266. PubMed ID: 27169860
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease.
Hendy OM; Elsabaawy MM; Aref MM; Khalaf FM; Oda AMA; El Shazly HM
APMIS; 2017 Jul; 125(7):607-613. PubMed ID: 28430371
[TBL] [Abstract][Full Text] [Related]
19. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
20. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
